Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps Clinical research trials and Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps. Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps clinical trial. Human subjects often get the best healthcare possible for their Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps

Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps



Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps

For Condition: Colon Cancer,prevention of colorectal cancer,Rectal Cancer
Status: No longer recruiting
Sponsor(s): Queen's Medical Centre ,
Synopsis: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin and/or folic acid may be effective in preventing recurrent polyps in patients who have had polyps removed previously. PURPOSE: Randomized clinical trial to determine the effectiveness of aspirin and/or folic acid in preventing the recurrence of colorectal polyps.
Details: OBJECTIVES: I. Determine whether aspirin and/or folic acid prevents recurrence of colorectal adenomas in patients who have had colorectal adenomas removed. PROTOCOL OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are randomized to 1 of 4 treatment arms. Arm I: Patients receive oral aspirin and oral folic acid daily. Arm II: Patients receive oral aspirin and oral placebo daily. Arm III: Patients receive oral placebo and oral folic acid daily. Arm IV: Patients receive 2 oral placebos daily. In all arms, treatment continues for 3 years in the absence of unacceptable toxicity. After completion of the 3-year intervention, all patients undergo a surveillance colonoscopy. PROJECTED ACCRUAL: A total of 1,300 patients will be accrued for this study.
Eligibility:
Study Type:
  Interventional, Prevention
Minimum Age/Maximum Age: /75 Years
Genders: 
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Histologically confirmed colorectal adenoma removed within the past 6 months - Greater than 0.5 cm after fixation or greater than 0.7 cm at time of removal OR - Any size with a history of prior colorectal adenoma removal(s) Removed via colonoscopy, flexi-sigmoidoscopy (provided barium enema has been performed), or transanal endoscopic microsurgery Removal must be considered complete with follow-up to be done within 6 months No prior resection of large bowel (e.g., hemi-colectomy or greater, anterior resection, or subtotal colectomy) --Prior/Concurrent Therapy-- Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: See Disease Characteristics Other: - No other concurrent folic acid - No concurrent anticoagulants - No other prior or concurrent non-steroidal anti-inflammatory drugs, prescribed or self-medicated (more than 3 tablets per week) --Patient Characteristics-- Age: 75 and under Performance status: Not specified Life expectancy: Not specified Hematopoietic: No active bleeding disorders Hepatic: Not specified Renal: Not specified Cardiovascular: No unstable heart conditions Pulmonary: No unstable asthma Other: - Not pregnant and no potential to become pregnant within the next 3 years - No unstable diabetes - No active upper gastrointestinal ulceration - No known aspirin intolerance or sensitivity - No other serious medical conditions that would preclude study
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
RichardLogan,  Study Chair,  Queen's Medical Centre

Whiston Hospital
Prescot Merseyside,  England,  L35 5DR
United Kingdom
 

University of Wales College of Medicine
Cardiff,  Wales,  CF14 4XN
United Kingdom
 

Birmingham Heartlands and Solihull NHS Trust (Teaching)
Birmingham,  England,  B9 5SS
United Kingdom
 

Royal Gwent Hospital
Newport Gwent,  ,  NP9 2UB
United Kingdom
 

City Hospital - Birmingham
Birmingham,  England,  B18 7QH
United Kingdom
 

Southport and Formby District General Hospital
Merseyside,  England,  PR8 6NJ
United Kingdom
 

Derby City General Hospital
Derby,  England,  DE22 3NE
United Kingdom
 

Salford Royal Hospitals NHS Trust
Salford,  England,  M6 8HD
United Kingdom
 

Nottingham City Hospital NHS Trust
Nottingham,  England,  NG5 1PB
United Kingdom
 

Southmead Hospital
Bristol,  England,  BS10 5NB
United Kingdom
 

Rotherham District General Hospital-NHS Trust
Rotherham,  ,  S60 2UD
United Kingdom
 

Frenchay Hospital
Bristol,  England,  BS16 1LE
United Kingdom
 

King's Mills Hospital
Nottinghamshire,  ,  NG17 4JL
United Kingdom
 

Merthyr Tydfil Hospital
Merthyr,  England, 
United Kingdom
 

Whiteabbey Hospital
Newtownabbey,  Northern Ireland, 
United Kingdom
 

Sheffield Teaching Hospitals
Sheffield,  England,  S1O 2JF
United Kingdom
 

Queen's Medical Centre
Nottingham,  England,  NG7 2UH
United Kingdom
 

Trafford General Hospital
Manchester,  England,  M31 3SL
United Kingdom
 

East Glamorgan Hospital
Lhantrisant,  ,  CF72 8XR
United Kingdom
 

Princess of Wales Hospital
Bridgend,  Wales,  CF31 1JP
United Kingdom
 

Northern General Hospital
Sheffield,  England,  S5 7AU
United Kingdom
 

North Manchester Healthcare NHS Trust
Manchester,  ,  M8 6RB
United Kingdom
 

Wythenshawe Hospital
Manchester,  England,  M23 9LJ
United Kingdom
 

Wordsley Hospital
Dudley,  England,  DY8 5QX
United Kingdom
 

Royal Victoria Hospital
Belfast,  Northern Ireland,  BT12 6BA
United Kingdom
 

Manchester Royal Infirmary
Manchester,  England,  M13 9WL
United Kingdom
 

Glenfield Hospital
Leicester,  England,  LE3 9QP
United Kingdom
 

Solihull Hospital
Solihull,  England,  B91 3AH
United Kingdom
 

Antrim Hospital
Antrim,  England,  BR41 2RL
United Kingdom
 

Royal Liverpool and Broadgreen Hospitals
Liverpool,  England,  L7 8XP
United Kingdom
 

Selly Oak Hospital
Birmingham,  ,  B29 6JD
United Kingdom
 

Bristol Royal Infirmary
Bristol,  England,  BS2 8HW
United Kingdom
 


Additional Information:
Study ID Numbers:
  CDR0000069273;  EU-20045,QMC-UKCAP
Study Start Date: May 1997
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033319

Other Prevention Of Colorectal Cancer Studies:
1. Gene Therapy in Treating Patients With Cancer

2. Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer

3. Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

4. Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

5. Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Related Studies:

Other prevention of colorectal cancer Clinical Trials
Other England Clinical Trials
Other Birmingham Clinical Trials

Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps

Modify your Search

  Other prevention of colorectal cancer Clinical Trials
  Other England Clinical Trials
  Other Birmingham Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103